Literature DB >> 431120

Idiopathic membranoproliferative (mesangiocapillary) glomerulonephritis: a clinicopathologic study.

J V Donadio, T K Slack, K E Holley, D M Ilstrup.   

Abstract

In 51 patients with type 1 and 9 patients with type 2 membranoproliferative glomerulonephritis, we found a male predominance in both types, a wide age range but with younger patients having predominantly type 2 disease, and clinical presentations that varied and included the nephrotic syndrome, an abnormal urinalysis only, acute nephritis, and recurrent hematuria. Hypertension and impaired renal function at the time of first evaluation, which were present in more than one-third of the patients, presaged a poor prognosis; in most of these patients end-stage renal failure or worsening of renal function occurred. Acute nephritis at onset was also related to a deteriorating course and was especially frequent in patients with type 2 membranoproliferative glomerulonephritis. Retrospective analysis of treatment regimens, in which patients were given an average of 1 year of therapy with prednisone alone or combined with cytotoxic agents, showed no effect in patients who had progressive forms of the glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 431120

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Efficacy of school urinary screening for membranoproliferative glomerulonephritis type 1.

Authors:  Y Kawasaki; J Suzuki; R Nozawa; H Suzuki
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

2.  Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.

Authors:  T Orlowski; Z Rancewicz; M Lao; J Juskowa; J Klepacka; L Gradowska; M Morzycka-Michalik; J Glyda
Journal:  Klin Wochenschr       Date:  1988-10-17

Review 3.  Idiopathic membranoproliferative glomerulonephritis in childhood.

Authors:  C D West
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

4.  Predictive factors for poor outcome in pediatric C3 glomerulonephritis.

Authors:  Mamiko Hosoya; Yukihiko Kawasaki; Ryo Maeda; Masatoki Sato; Kazuhide Suyama; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2018-10-27

Review 5.  Dense deposit disease and C3 glomerulopathy.

Authors:  Thomas D Barbour; Matthew C Pickering; H Terence Cook
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.